Current Treatment Options in Rheumatology
Q4IF1.3SJR0.320
CH
CHJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2024 | 1.3 | Q4 | 25.9% | — | — | |
| 2023 | 1.7 | Q3 | 36.8% | — | — | |
| 2022 | 1.2 | 21.8% | — | — | ||
| 2021 | — | 34.6% | — | — | ||
| 2019 | — | — | 0.320 | Q3 | 54.4% | |
| 2018 | — | — | 0.313 | Q3 | 51.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2198-6002
country
CH